Literature DB >> 7023389

Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.

A Aynsley-Green, J M Polak, S R Bloom, M H Gough, J Keeling, S J Ashcroft, R C Turner, J D Baum.   

Abstract

Three newborn infants are reported who developed severe non-ketotic hypoglycaemia (blood glucose less than 1.1 mmol/l; 19.8 mg/100 ml) within 6 hours of birth. All had inappropriately raised plasma insulin concentrations for the level of glycaemia, and required high rates of glucose infusion (less than 15 mg glucose/kg per minute) to prevent symptoms of hypoglycaemia. Medical treatment (hydrocortisone, diazoxide, chlorothiazide, phenytoin, propranolol, and depot glucagon) was ineffective in preventing hypoglycaemia and all 3 infants were subjected to partial and then total pancreatectomy. The pathological features of nesidioblastosis are reported from quantitative immunohistochemical studies on the pancreata. These results together with those from metabolic and endocrine studies performed on the 3 infants during the investigation of the cause of the hypoglycaemia and during the preoperative and postoperative period are presented in detail in order to define a practical approach to the management of this difficult clinical problem in the neonate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023389      PMCID: PMC1627357          DOI: 10.1136/adc.56.7.496

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  50 in total

1.  Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma.

Authors:  I Blum; M Doron; Z Laron; A Atsmon; P Tiqva
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

2.  Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.

Authors:  R C Turner; L G Heding
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

3.  Islet-cell tumour causing hypoglycaemia in a newborn infant.

Authors:  D B Grant; P R Barbor
Journal:  Arch Dis Child       Date:  1970-06       Impact factor: 3.791

4.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

5.  Enzymes of ketone-body utilisation in human brain.

Authors:  M A Page; D H Williamson
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

6.  Functioning islet cell adenoma in the newborn. Report of a case with failure of diazoxide.

Authors:  E D Salinas; H H Mangurten; S S Roberts; W H Simon; M Cornblath
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

7.  A possible role for the exocrine pancreas in the pathogenesis of neonatal leucine-sensitive hypoglycemia.

Authors:  R E Brown; R B Young
Journal:  Am J Dig Dis       Date:  1970-01

8.  Islet-cell hyperplasia and sudden infant death.

Authors:  J N Cox; G Guelpa; M Terrapon
Journal:  Lancet       Date:  1976-10-02       Impact factor: 79.321

9.  Letter: Islet-cell hyperplasia and sudden infant death.

Authors:  J M Polak; J S Wigglesworth
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

10.  Thiosulfation aldehyde fuchsin (TAF) procedure for the staining of pancreatic B cells.

Authors:  G Bussolati; T Bassa
Journal:  Stain Technol       Date:  1974-09
View more
  42 in total

1.  A child presenting with disordered consciousness, hallucinations, screaming episodes and abdominal pain.

Authors:  Khalid Hussain; Helen Mundy; Albert Aynsley-Green; Michael Champion
Journal:  Eur J Pediatr       Date:  2002-02       Impact factor: 3.183

2.  Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.

Authors:  C Kane; K J Lindley; P R Johnson; R F James; P J Milla; A Aynsley-Green; M J Dunne
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Hyperinsulinism induced by targeted suppression of beta cell KATP channels.

Authors:  J C Koster; M S Remedi; T P Flagg; J D Johnson; K P Markova; B A Marshall; C G Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 4.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

5.  Histochemical, clinical, and in vitro beta cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy.

Authors:  N S Panesar; C W Poon; C T Liew; G W Wong; N M Hjelm
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

6.  Glucose metabolism in a term infant with transient hyperinsulinism and high carbohydrate intake.

Authors:  J B van Goudoever; E J Sulkers; S C Kalhan; P J Sauer
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

7.  The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells?

Authors:  J Rahier; K Fält; H Müntefering; K Becker; W Gepts; S Falkmer
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

8.  Management of secondary diabetes mellitus after total pancreatectomy in infancy.

Authors:  S A Greene; A Aynsley-Green; G Soltesz; J D Baum
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

9.  Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood.

Authors:  L Spitz; R K Bhargava; D B Grant; J V Leonard
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

10.  Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis.

Authors:  L W Martin; F C Ryckman; C A Sheldon
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.